Statement on Rep. Matsui Introduction of SERV Communities Act
The bill would bring relief to essential hospitals and their patients from damaging Medicare outpatient payment cuts and much-needed accountability for manufacturers in the 340B Drug Pricing Program. (June 12, 2018)
HRSA Should Revisit Delay of 340B Rule
The delay enables manufacturer overcharges that jeopardize access to affordable drugs for vulnerable patients and drive up costs for hospitals. (June 1, 2018)
Statement on Avalere Analysis of 340B Payment Policy in 2018 OPPS
This badly misleading report makes no attempt to focus on or isolate the 340B drug payment policy. Rather, it masks the policy’s damaging impact by conflating it with other unrelated policy changes. (Jan. 29, 2018)
Issue Briefs and Comment Letters
Print and Social
Print and share these two-page PDF fliers.
Click and then right click to download full-size images.